- Home
- PEPG vs TACT Comparison
PEPG vs TACT Comparison
Compare PEPG & TACT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PEPG
- TACT
- Stock Information
- Founded
- PEPG 2018
- TACT 1996
- Country
- PEPG United States
- TACT United States
- Employees
- PEPG N/A
- TACT N/A
- Industry
- PEPG Biotechnology: Pharmaceutical Preparations
- TACT Computer peripheral equipment
- Sector
- PEPG Health Care
- TACT Technology
- Exchange
- PEPG Nasdaq
- TACT Nasdaq
- Market Cap
- PEPG 45.9M
- TACT 42.2M
- IPO Year
- PEPG 2022
- TACT 1996
- Fundamental
- Price
- PEPG $2.56
- TACT $5.36
- Analyst Decision
- PEPG Buy
- TACT Strong Buy
- Analyst Count
- PEPG 4
- TACT 1
- Target Price
- PEPG $7.25
- TACT $5.00
- AVG Volume (30 Days)
- PEPG 633.9K
- TACT 91.5K
- Earning Date
- PEPG 11-06-2025
- TACT 11-06-2025
- Dividend Yield
- PEPG N/A
- TACT N/A
- EPS Growth
- PEPG N/A
- TACT N/A
- EPS
- PEPG N/A
- TACT N/A
- Revenue
- PEPG N/A
- TACT $47,949,000.00
- Revenue This Year
- PEPG N/A
- TACT $21.67
- Revenue Next Year
- PEPG N/A
- TACT $7.63
- P/E Ratio
- PEPG N/A
- TACT N/A
- Revenue Growth
- PEPG N/A
- TACT N/A
- 52 Week Low
- PEPG $0.88
- TACT $3.12
- 52 Week High
- PEPG $9.94
- TACT $5.48
- Technical
- Relative Strength Index (RSI)
- PEPG 74.19
- TACT 77.00
- Support Level
- PEPG $1.82
- TACT $4.54
- Resistance Level
- PEPG $2.24
- TACT $5.48
- Average True Range (ATR)
- PEPG 0.28
- TACT 0.19
- MACD
- PEPG 0.09
- TACT 0.07
- Stochastic Oscillator
- PEPG 97.64
- TACT 84.76
About PEPG PepGen Inc.
PepGen Inc is a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapeutics to transform the treatment of severe neuromuscular and neurologic diseases. The company has developed its Enhanced Delivery Oligonucleotide platform to improve the uptake and activity of conjugated oligonucleotide therapeutics. Its EDO peptides are engineered to optimize tissue penetration, cellular uptake, and nuclear delivery, and in preclinical studies, it is observed their ability to transport oligonucleotides into a broad range of target tissues, including smooth, skeletal, and cardiac muscle and the central nervous system. Its pipeline products are; PGN-EDO51, PGN-EDODM1, and others including PGN-EDO53 and PGN-EDO45.
About TACT TransAct Technologies Incorporated
Transact Technologies Inc develops and sells software-driven technology and printing solutions. The company's software is sold under BOHA, AccuDate, Epic, EPICENTRAL, Ithaca, and Printrex brand names. It also provides supplies and consumables used in the printing and scanning activities to restaurant and hospitality, banking, retail, casino and gaming, point of sale automation, lottery, medical, mobile, oil, and gas markets. Majority of the revenue is derived from the casinos and gaming industry followed by the Foodservice technology market. Its geographical segments are the United States and International, of which the majority of its revenue comes from the United States.